Prof. Adnan AYDINER

Published journal articles indexed by SCI, SSCI, and AHCI

Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group

Gurbuz M., Kutlu Y., AKKUŞ E., KÖKSOY E. B., Kose N., Oven B. B., et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, vol.148, no.12, pp.3547-3555, 2022 (SCI-Expanded) Sustainable Development

Toxicity management and efficacy of carboplatin desensitization therapy for recurrent epithelial ovarian carcinoma: A real-world study

PAKSOY N., KHANMAMMADOV N., DOĞAN İ., FERHATOĞLU F., YILDIZ A., AK N., et al.

Medicine (United States), vol.101, no.45, 2022 (SCI-Expanded) Sustainable Development

The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study)

Hizal M., Bilgin B., Paksoy N., Atci M. M., KAHRAMAN S., Kilickap S., et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022 (SCI-Expanded)

Evaluation of clinicopathological features determining treatment response in patients with ALK mutant NSCLC

DOĞAN İ., Gurbuz M., Paksoy N., Ferhatoglu F., Vatansever S., Saip P., et al.

MEDICINE, vol.101, no.34, 2022 (SCI-Expanded)

Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study

Hizal M., Bilgin B., Paksoy N., Kilickap S., Atci M. M., KAHRAMAN S., et al.

FUTURE ONCOLOGY, vol.18, pp.2573-2582, 2022 (SCI-Expanded) Sustainable Development

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination.

Dogan I., Paksoy N., Ak N., Vatansever S., Saip P., Aydiner A.

JOURNAL OF CLINICAL ONCOLOGY, vol.40, no.16, 2022 (SCI-Expanded)

The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study

Hizal M., Bilgin B., Paksoy N., Acikgoz O., Sezer A., Gurbuz M., et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, vol.148, no.6, pp.1501-1508, 2022 (SCI-Expanded) Sustainable Development

Recurrent autoimmune encephalitis related to immune checkpoint inhibitors

Ser M. H., Samanci N. S., Naziye A. K., Aydiner A., Ozkara C.

EPILEPTIC DISORDERS, vol.24, no.3, pp.609-613, 2022 (SCI-Expanded)

Are false-negative rates of sentinel lymph node biopsy after neoadjuvant chemotherapy really associated with poor prognosis in clinically node-positive disease at diagnosis?

Cabioglu N., Karanlik H., Igci A., Muslumanoglu M., Tukenmez M., Emiroglu S., et al.

ANNALS OF SURGICAL ONCOLOGY, vol.29, no.SUPPL 1, pp.310-311, 2022 (SCI-Expanded)

Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study

Cil I., Kucukarda A., Atci M. M., Secmeler S., Paksoy N., Ferhatoglu F., et al.

TUMORI JOURNAL, vol.108, no.1, pp.19-25, 2022 (SCI-Expanded) Sustainable Development

Demonstration of in vivo estrogen receptor status with 16 alpha- [F-18]fluoro-17 beta-oestradiol (FES) PET/CT in a rare case of benign metastasizing leiomyoma

Has Simsek D., Kuyumcu S., Ozkan Z. G., Vuralli Bakkaloglu D., Bayram A., Topuz S., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol.48, no.12, pp.4101-4102, 2021 (SCI-Expanded)

Nivolumab treatment for metastatic thymic epithelial tumors.

Ak N., Aydiner A.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, vol.27, pp.1710-1715, 2021 (SCI-Expanded)

Sentinel Lymph Node Biopsy May Prevent Unnecessary Axillary Dissection in Patients with Inflammatory Breast Cancer Who Respond to Systemic Treatment

Karanlik H., CABIOĞLU N., Oprea A. L., ÖZGÜR İ., AK N., AYDINER A., et al.

BREAST CARE, vol.16, no.5, pp.468-474, 2021 (SCI-Expanded) Sustainable Development

Outcomes of thymoma after multimodal therapy and determinants of survival: A 16-year experience of a tertiary cancer center

Ak N., Toker A., Kara M., Ozkan B., Ulker M., Kaba E., et al.

TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, vol.29, no.4, pp.487-495, 2021 (SCI-Expanded) Sustainable Development

Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy

Oner G., Onder S., Karatay H., Ak N., Tukenmez M., Muslumanoglu M., et al.

WORLD JOURNAL OF SURGICAL ONCOLOGY, vol.19, no.1, 2021 (SCI-Expanded) Sustainable Development

The role of adjuvant chemotherapy in resected stage I non - small cell lung cancer: A Turkish Oncology Group Study

Ak N., Ozkan B., Yenigun M. B., Yilmazbayhan D., Toker A., Ferhatoglu F., et al.

JOURNAL OF BUON, vol.26, no.3, pp.819-829, 2021 (SCI-Expanded) Sustainable Development

Long-term outcomes and predictors of recurrence in patients with early-stage node negative breast cancer.

Dogan I., Aydin E., Paksoy N., Ferhatoglu F., Ak N., Ibis K., et al.

JOURNAL OF CLINICAL ONCOLOGY, vol.39, no.15, 2021 (SCI-Expanded) Sustainable Development

Predictors of response in EGFR-mutant metastatic non-small cell lung cancer patients treated with tyrosine kinase inhibitors.

Aydiner A., Dogan I., Khanmammadov N., Saip P., Vatansever S.

JOURNAL OF CLINICAL ONCOLOGY, vol.39, no.15, 2021 (SCI-Expanded) Sustainable Development

TIM3 expression on TILs is associated with poor response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer

Cabioglu N., Onder S., Oner G., Karatay H., Tukenmez M., Muslumanoglu M., et al.

BMC CANCER, vol.21, no.1, 2021 (SCI-Expanded) Sustainable Development

Sentinel lymph node biopsy alone in locally advanced breast cancer after neoadjuvant chemotherapy: Turkish multicentric neosenti-turk MF-18-02-study

Cabioglu N., Karanlik H., Muslumanoglu M., Cakmak G. K., Trablus D. C., Tukenmez M., et al.

CANCER RESEARCH, vol.81, no.4, 2021 (SCI-Expanded) Sustainable Development

Outcomes of metastatic male breast cancer

Dogan I., Khanmammadov N., Aydiner A., Saip P.

CANCER RESEARCH, vol.81, no.4, 2021 (SCI-Expanded) Sustainable Development

Termination of trastuzumab-based treatment after complete response in HER2-positive metastatic breast cancer

Dogan I., Aydin E., Khanmammadov N., Aydiner A., Saip P.

CANCER RESEARCH, vol.81, no.4, 2021 (SCI-Expanded) Sustainable Development

Tim3 expression on tumor infiltrating lymphocytes is associated with poor response to neoadjuvan chemotherapy in patients with locally advanced triple negative breast cancer

Cabioglu N., Onder S., Oner G., Karatay H., Tukenmez M., Muslumanoglu M., et al.

CANCER RESEARCH, vol.81, no.4, 2021 (SCI-Expanded) Sustainable Development

GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients

Peled N., Gillis R., KILIÇKAP S., Froesch P., Orlov S., Filippova E., et al.

LUNG CANCER, vol.148, pp.48-54, 2020 (SCI-Expanded)

Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial

Demir A., Mandel N. M., PAYDAŞ S., Demir G., ER O., Turhal N. S., et al.

BALKAN MEDICAL JOURNAL, vol.37, no.2, pp.104-107, 2020 (SCI-Expanded) Sustainable Development

Rare mutations of epidermal growth factor receptor in epidermal growth factor receptor-tyrosine kinase inhibitor-naive non-small cell lung carcinoma and the response to erlotinib therapy

Sari M., Aydiner A.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, vol.16, no.1, pp.132-138, 2020 (SCI-Expanded) Sustainable Development

Epidermal growth factor receptor (EGFR) exon 20 mutations in EGFR-tyrosine kinase inhibitors (EGFR-TKIs) naive non-small cell lung carcinoma (NSCLC) and response to erlotinib therapy

AYDINER A., Sari M.

JOURNAL OF CLINICAL ONCOLOGY, vol.36, no.15, 2018 (SCI-Expanded)

High expression of pdl-1 in patients with triple negative breast cancer with residual tumor burden after neoadjuvant chemotherapy.

Oner G., Önder S., Karatay H., Tükenmez M., Muslumanoglu M., Igci A., et al.

JOURNAL OF CLINICAL ONCOLOGY, vol.36, 2018 (SCI-Expanded) Sustainable Development

Effect of the childhood trauma on the adjustment to cancer in the patients with breast cancer

Guveli H., Guveli M. E., Sen F., Oflaz S., Gurdal N., Tambas M., et al.

BREAST CANCER, vol.24, no.4, pp.544-551, 2017 (SCI-Expanded) Sustainable Development

Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy

Sen F., Tambas M., Ozkaya K., Guveli M. E., Ciftci R., Ozkan B., et al.

MEDICINE, vol.95, no.30, 2016 (SCI-Expanded) Sustainable Development

Is there any effect of first-day usage of a totally implantable venous access device on complications?

Karanlik H., Odabas H., Yildirim I., Ozgur I., Kilic B., Sen F., et al.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, vol.20, no.6, pp.1057-1062, 2015 (SCI-Expanded)

Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer Survival and Response to Treatment

Aydiner A., Sen F., Tambas M., Ciftci R., Eralp Y., Saip P., et al.

MEDICINE, vol.94, no.52, 2015 (SCI-Expanded) Sustainable Development

Concomitant Chemoradiotherapy with Etoposide & Cisplatin versus Docetaxel & Cisplatin in Locally Advanced Non-Small Cell Lung Cancer

Eralp Y., Sen F., Tambas M., Ozkaya K., Ozkan B., Oral E. N., et al.

JOURNAL OF THORACIC ONCOLOGY, vol.10, no.9, 2015 (SCI-Expanded) Sustainable Development

Renin-Angiotensin System Blockers May Prolong Survival of Metastatic Non-Small Cell Lung Cancer Patients Receiving Erlotinib

Aydiner A., Ciftci R., Sen F.

MEDICINE, vol.94, no.22, 2015 (SCI-Expanded) Sustainable Development

Effects of Distant Reiki On Pain, Anxiety and Fatigue in Oncology Patients in Turkey: A Pilot Study.

DEMIR M., Can G., KELAM A., AYDINER A.

Asian Pacific journal of cancer prevention : APJCP, vol.16, pp.4859-62, 2015 (SCI-Expanded)

A comparison of men and women's experiences of chemotherapy-induced alopecia

Can G., Demir M., Erol O., Aydiner A.

EUROPEAN JOURNAL OF ONCOLOGY NURSING, vol.17, no.3, pp.255-260, 2013 (SCI-Expanded) Sustainable Development

Meta-analysis of breast cancer outcome and toxicity in adjuvant trials of aromatase inhibitors in postmenopausal women

Aydiner A.

BREAST, vol.22, no.2, pp.121-129, 2013 (SCI-Expanded) Sustainable Development

Two different formulations with equivalent effect? Comparison of serum estradiol suppression with monthly goserelin and trimonthly leuprolide in breast cancer patients

Aydiner A., Kilic L., Yildiz I., Keskin S., Sen F., Kucucuk S., et al.

MEDICAL ONCOLOGY, vol.30, no.1, 2013 (SCI-Expanded) Sustainable Development

Clinical Outcomes and Prognostic Factors Associated with the Response to Erlotinib in Non-Small-Cell Lung Cancer Patients with Unknown EGFR Mutational Status

Aydiner A., Yildiz I., Seyidova A.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.14, no.5, pp.3255-3261, 2013 (SCI-Expanded) Sustainable Development

The efficiency of the acupressure in prevention of the chemotherapy-induced nausea and vomiting

Genc A., Can G., Aydiner A.

SUPPORTIVE CARE IN CANCER, vol.21, no.1, pp.253-261, 2013 (SCI-Expanded)

Does Beta-blocker Therapy Improve the Survival of Patients with Metastatic Non-small Cell Lung Cancer?

Aydiner A., Ciftci R., Karabulut S., Kilic L.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.14, no.10, pp.6109-6114, 2013 (SCI-Expanded) Sustainable Development

Effects of alopecia on body image and quality of life of Turkish cancer women with or without headscarf

Erol O., Can G., Aydiner A.

SUPPORTIVE CARE IN CANCER, vol.20, no.10, pp.2349-2356, 2012 (SCI-Expanded) Sustainable Development

Association of clinical and pathological variables with survival in thymoma.

Aydiner A., Toker A., Sen F., Bicakci E., Saglam E. K., Erus S., et al.

Medical oncology (Northwood, London, England), vol.29, no.3, pp.2221-8, 2012 (SCI-Expanded) Sustainable Development

Taxane-induced nail changes: Predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity

Can G., Aydiner A., Cavdar I.

EUROPEAN JOURNAL OF ONCOLOGY NURSING, vol.16, no.3, pp.270-275, 2012 (SCI-Expanded)

The roles of surgery and EMA/CO chemotherapy regimen in primary refractory and non-refractory gestational trophoblastic neoplasia

Aydiner A., Keskin S., Berkman S., Bengisu E., Ilhan H. R., Tas F., et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, vol.138, no.6, pp.971-977, 2012 (SCI-Expanded)

Complementary and Alternative Therapies Used by Turkish Breast Cancer Patients Undergoing Chemotherapy

Can G., Demir M., Aydiner A.

BREAST CARE, vol.7, no.6, pp.471-475, 2012 (SCI-Expanded) Sustainable Development

Complete Response in a Patient with Granulosa Cell Tumor Treated with a Combination of Leuprolide and Tamoxifen

Keskin S., Bengisu E., Tuzlali S., Aydiner A.

ONKOLOGIE, vol.35, pp.451-453, 2012 (SCI-Expanded) Sustainable Development

Induction Chemotherapy With Triweekly Docetaxel and Cisplatin Followed by Concomitant Chemoradiotherapy With or Without Surgery in Stage III Non-Small-Cell Lung Cancer: A Phase II Study

Aydiner A., Sen F., SAGLAM E. K., Oral E. N., Eralp Y., Tas F., et al.

CLINICAL LUNG CANCER, vol.12, no.5, pp.286-292, 2011 (SCI-Expanded) Sustainable Development

Non-pharmacological interventions used by cancer patients during chemotherapy in Turkey

Can G., Erol O., Aydiner A., Topuz E.

EUROPEAN JOURNAL OF ONCOLOGY NURSING, vol.15, no.2, pp.178-184, 2011 (SCI-Expanded) Sustainable Development

Development and validation of the Nightingale Symptom Assessment Scale (N-SAS) and predictors of the quality of life of the cancer patients in Turkey

Can G., Aydiner A.

EUROPEAN JOURNAL OF ONCOLOGY NURSING, vol.15, no.1, pp.3-11, 2011 (SCI-Expanded) Sustainable Development

Quality of life, symptom experience and distress of lung cancer patients undergoing chemotherapy

Akin S., Can G., Aydiner A., Ozdilli K., Durna Z.

EUROPEAN JOURNAL OF ONCOLOGY NURSING, vol.14, no.5, pp.400-409, 2010 (SCI-Expanded) Sustainable Development

The validity and reliability of the Turkish version of the Quality of Life Index [QLI] (Cancer version)

Can G., Durna Z., Aydiner A.

EUROPEAN JOURNAL OF ONCOLOGY NURSING, vol.14, no.4, pp.316-321, 2010 (SCI-Expanded) Sustainable Development

Quality of life and complementary and alternative medicine use among cancer patients in Turkey

Can G., Erol O., Aydiner A., Topuz E.

EUROPEAN JOURNAL OF ONCOLOGY NURSING, vol.13, no.4, pp.287-294, 2009 (SCI-Expanded) Sustainable Development

The role of third generation agents as an induction treatment in concurrent chemoradiotherapy (CRT) for locally-advanced non-small cell lung cancer: a systematic review and meta-analysis of randomized clinical trials

Aydiner A., Can G.

JOURNAL OF THORACIC ONCOLOGY, vol.4, no.9, 2009 (SCI-Expanded) Sustainable Development

Detection of Human Papillomavirus DNA by PCR and Southern Blot Hybrizidation in Colorectal cancer Patients

SALEPCİ T., YAZICI ÖZBEK H., DANE F., Topuz E., DALAY M. N., ONAT H., et al.

JOURNAL OF BUON, vol.14, no.3, pp.495-499, 2009 (SCI-Expanded) Sustainable Development

Immune changes in patients with locally advanced breast cancer receiving neoadjuvant chemotherapy

Cabioǧlu N., Müslümanoǧlu M. E., Tütüncü Y., Adin-Cinar S., Gürel N., KIRAN B., et al.

Turkish Journal of Immunology, vol.13, no.1, pp.15-20, 2008 (SCI-Expanded) Sustainable Development

The quality of life and self-efficacy of Turkish breast cancer patients undergoing chemotherapy

Akin S., Can G., Durna Z., Aydiner A.

EUROPEAN JOURNAL OF ONCOLOGY NURSING, vol.12, no.5, pp.449-456, 2008 (SCI-Expanded) Sustainable Development

Evaluation of the effect of care given by nursing students on oncology patients' satisfaction

Can G., Akin S., Aydiner A., Ozdilli K., Durna Z.

EUROPEAN JOURNAL OF ONCOLOGY NURSING, vol.12, no.4, pp.387-392, 2008 (SCI-Expanded)

Chemotherapy with pegylated liposomal doxorubicin and cisplatin in recurrent platinum-sensitive epithelial ovarian cancer

Tas F., Derin D., Guney N., Aydiner A., Topuz E.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, vol.13, no.4, pp.330-334, 2008 (SCI-Expanded) Sustainable Development

Biweekly administration of gemcitabine and cisplatin chemotherapy in patients with anthracycline and taxane-pretreated metastatic breast cancer

Tas F., Guney N., Derin D., Camlica H., Aydiner A., Topuz E.

INVESTIGATIONAL NEW DRUGS, vol.26, no.4, pp.363-368, 2008 (SCI-Expanded) Sustainable Development

Meta-analysis of trials comparing anastrozole and tamoxifen for adjuvant treatment of postmenopausal women with early breast cancer

Aydiner A., Tas F.

TRIALS, vol.9, 2008 (SCI-Expanded) Sustainable Development

Evaluation of sexual function of Turkish women with breast cancer receiving systemic treatment

Can G., Oskay U., DURNA Z., Aydiner A., Saip P., Disci R., et al.

ONCOLOGY NURSING FORUM, vol.35, no.3, pp.471-476, 2008 (SCI-Expanded) Sustainable Development

A pilot study evaluating the efficacy and toxicity of biweekly gemcitabine and pegylated liposomal doxorubicin in recurrent platinum-resistant epithelial ovarian cancer

Tas F., Guney N., Derin D., Aydiner A., Topuz E.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, vol.13, no.2, pp.156-160, 2008 (SCI-Expanded) Sustainable Development

Memenin filloides tümörlerinde tedavi yaklaşımları

CABIOĞLU N., ÇELİK O. T., ÖZMEN V., İĞCİ A., MÜSLÜMANOĞLU M. E., ÖZÇINAR B., et al.

Meme Sağlığı Dergisi, vol.4, pp.99-104, 2008 (SCI-Expanded)

Addition of topotecan to standard cisplatin/etoposide combination in patients with extended stage small cell lung carcinoma

Tas F., Derin D., Guney N., Camlica H., Aydiner A., Topuz E.

LUNG CANCER, vol.57, no.1, pp.79-83, 2007 (SCI-Expanded) Sustainable Development

The efficacy of tamoxifen in patients with advanced epithelial ovarian cancer

Karagol H., Saip P., Uygun K., Caloglu M., Eralp Y., Tas F., et al.

MEDICAL ONCOLOGY, vol.24, no.1, pp.39-43, 2007 (SCI-Expanded) Sustainable Development

Increased sister chromatid exchange frequency in young women with breast cancer and in their first-degree relatives.

Cefle K., Ucur A., Guney N., Ozturk S., Palanduz S., Tas F., et al.

Cancer genetics and cytogenetics, vol.171, pp.65-7, 2006 (SCI-Expanded) Sustainable Development

Evaluation of prognostic factors and comparison of systemic treatment modalities in patients with recurrent or metastatic endometrial carcinoma

Karagol H., Saip P., Uygun K., Kucucuk S., Aydiner A., Topuz E.

MEDICAL ONCOLOGY, vol.23, no.4, pp.543-548, 2006 (SCI-Expanded)

Induction and concurrent chemotherapy with concomitant boost radiotherapy in non-small cell lung cancer

Oral E. N., AYDINER A., ERALP Y., TOPUZ E.

MEDICAL ONCOLOGY, vol.22, no.4, pp.367-374, 2005 (SCI-Expanded) Sustainable Development

Clinical value of protein S100 and melanoma-inhibitory activity (MIA) in malignant melanoma.

TAS F., Yasasever V., DURANYILDIZ D., CAMLICA H., USTUNER Z., AYDINER A., et al.

American journal of clinical oncology, vol.27, no.3, pp.225-8, 2004 (SCI-Expanded)

Assessment of fatigue in and care needs of Turkish women with breast cancer

Can G., Durna Z., Aydiner A.

CANCER NURSING, vol.27, no.2, pp.153-161, 2004 (SCI-Expanded) Sustainable Development

Inflammatory breast cancer: Results of antracycline-based neoadjuvant chemotherapy

Ozmen V., Cabioglu N., Igci A., Dagoglu T., AYDINER A., Kecer M., et al.

Breast Journal, vol.9, no.2, pp.79-85, 2003 (SCI-Expanded) Sustainable Development

Resectable thymoma: Treatment outcome and prognostic factors in the late adolescent and adult age group

ERALP Y., AYDINER A., Kizir A., KAYTAN E., ORAL E., TOPUZ E.

CANCER INVESTIGATION, vol.21, no.5, pp.737-743, 2003 (SCI-Expanded)

Acetaminophen modulations of chemotherapy efficacy in MDAH 2774 human endometrioid ovarian cancer cells in vitro

BILIR A., ALTINOZ M., Attar E., ERKAN M., AYDINER A.

NEOPLASMA, vol.49, no.1, pp.38-42, 2002 (SCI-Expanded) Sustainable Development

Thymidine labeling index in epithelial ovarian cancer

Salihoglu Y., Bilir A., Aydiner A., ERKAN M., TUZLALI S., ERALP Y.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, vol.75, no.2, pp.171-176, 2001 (SCI-Expanded) Sustainable Development

Biological considerations in locally advanced breast cancer treated with anthracycline-based neoadjuvant chemotherapy: thymidine labelling index is an independent indicator of clinical outcome

Ozmen V., CABIOGLU N., DOLAY K., BILIR A., KECER M., AYDINER A., et al.

BREAST CANCER RESEARCH AND TREATMENT, vol.68, no.2, pp.147-157, 2001 (SCI-Expanded) Sustainable Development

Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer.

TAS F., AYKAN F., AYDINER A., Yasasever V., TOPUZ E.

American journal of clinical oncology, vol.24, no.2, pp.148-9, 2001 (SCI-Expanded) Sustainable Development

Autophagy and nuclear changes in FM3A breast tumor cells after epirubicin, medroxyprogesterone and tamoxifen treatment in vitro

BILIR A., ALTINOZ M., ERKAN M., Ozmen V., AYDINER A.

PATHOBIOLOGY, vol.69, no.3, pp.120-126, 2001 (SCI-Expanded) Sustainable Development

Hypertrophic osteoarthropathy associated with docetaxel treatment.

Tas F., Aydiner A., Tenekeci N., Karadeniz A. N., Sakar B., Topuz E.

Clinical oncology (Royal College of Radiologists (Great Britain)), vol.13, no.2, pp.145-6, 2001 (SCI-Expanded)

Angiogenesis and p53 protein expression in breast cancer - Prognostic roles and interrelationships

TAS F., Yavuz E., AYDINER A., SAİP P., DISCI R., IPLIKCI A., et al.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, vol.23, no.6, pp.546-553, 2000 (SCI-Expanded) Sustainable Development

Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.

Tas F., Aydiner A., Topuz E., YASASEVER V., Karadeniz A. N., Saip P. M.

Journal of experimental & clinical cancer research : CR, vol.19, no.4, pp.477-81, 2000 (SCI-Expanded) Sustainable Development

Multiple primary neoplasms at a single institution: differences between synchronous and metachronous neoplasms.

Aydiner A., Karadeniz A. N., Uygun K., Tas S., Tas F., Disci R., et al.

American journal of clinical oncology, vol.23, no.4, pp.364-70, 2000 (SCI-Expanded) Sustainable Development

Celsite (R) port and catheter as an intraperitoneal access device in the treatment of ovarian cancer

TOPUZ E., Salihoglu Y., AYDINER A., Saip P. M., TAS F., SOZEN T., et al.

JOURNAL OF SURGICAL ONCOLOGY, vol.74, no.3, pp.223-226, 2000 (SCI-Expanded) Sustainable Development

Long term results and prognostic factors of granulosa cell tumors of the ovary.

SAİP P. M., Uygun K., Topuz E., BAŞARAN M., TAŞ F., AYDINER A., et al.

ANNALS OF ONCOLOGY, vol.11, pp.87, 2000 (SCI-Expanded)

Correlations of serum CA125 level and computerized tomography (CT) imaging with laparotomic findings following intraperitoneal chemotherapy in patients with ovarian cancer.

TOPUZ E., AYDINER A., Saip P. M., ERALP Y., TAS F., Salihoglu Y., et al.

European journal of gynaecological oncology, vol.21, no.6, pp.599-602, 2000 (SCI-Expanded) Sustainable Development

The role of chemotherapy in malignant mixed mullerian tumors of the female genital tract.

TOPUZ E., ERALP Y., AYDINER A., Saip P. M., TAS F., YAVUZ E., et al.

ANNALS OF ONCOLOGY, vol.11, pp.87-88, 2000 (SCI-Expanded)

Clinical pharmacokinetic comparative crossover study between three times a day and once a day-oral administration of etoposide

AYDINER A., KOYUNCU H., TOPUZ E., Disci R.

EUROPEAN JOURNAL OF CANCER, vol.35, 1999 (SCI-Expanded)

Response evaluation of bone metastases in breast cancer: Value of magnetic resonance imaging

SAIP P. M., TENEKECI N., AYDINER A., DINCER M., INANC S., DEMIR C., et al.

CANCER INVESTIGATION, vol.17, no.8, pp.575-580, 1999 (SCI-Expanded) Sustainable Development

Prediction of radiological response of bone metastases to therapy by biochemical marker monitoring in patients with breast cancer: A preliminary study

SAIP P. M., YASASEVER V., TENEKECI N., AYDINER A., INANC S., ONAT H., et al.

JOURNAL OF TUMOR MARKER ONCOLOGY, vol.13, no.3, pp.45-52, 1998 (SCI-Expanded) Sustainable Development

Catheter complications associated with intraperitoneal chemotherapy

TOPUZ E., Saip P. M., AYDINER A., Salihoglu Y., YILMAZ T., TOPUZLU C.

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, vol.19, no.3, pp.275-279, 1998 (SCI-Expanded) Sustainable Development

Intraperitoneal cisplatin-mitoxantrone and intravenous ifosfamide combination as first-line treatment of ovarian cancer

TOPUZ E., Saip P. M., Aydiner A., Salihoglu Y., BERKMAN S., BENGISU E.

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, vol.19, no.3, pp.265-270, 1998 (SCI-Expanded) Sustainable Development

The effect of the interval between surgery and radiotherapy on local control and overall survival in patients with breast cancer

OZSEKER N., ASLAY I., DINCER M., OZBILEN S., AYDINER A., OZTURK N., et al.

EUROPEAN JOURNAL OF CANCER, vol.33, pp.363, 1997 (SCI-Expanded) Sustainable Development

The effects of different treatment models on Turkish women with uterine sarcoma

BERRAK E., ASLAY I., OZTURK N., DINCER M., AYDINER A., OZBILEN S., et al.

EUROPEAN JOURNAL OF CANCER, vol.33, pp.943, 1997 (SCI-Expanded) Sustainable Development

Intraperitoneal cisplatin - mitoxantrone in ovarian cancer patients with minimal residual disease

TOPUZ E., AYDINER A., SAIP P. M., BENGISU E., BERKMAN S., Disci R.

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, vol.18, no.1, pp.71-75, 1997 (SCI-Expanded) Sustainable Development

ACUTE MYOCARDIAL-INFARCTION IN MAN TREATED WITH EPIRUBICIN FOR NON-HODGKIN-LYMPHOMA

AYDINER A., BUGRA Z., TOPUZ E., MERIC M.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, vol.18, no.5, pp.444-448, 1995 (SCI-Expanded)

A comparison of body image, self-esteem and social supporr in total mastectomy and breast-conserving therapy in Turkish women

Alçalar A. N., Aydıner A., Özkan S.

Supportive Care In Cancer, vol.2, pp.238-241, 1994 (SCI-Expanded)

SERUM TUMOR-MARKERS FOR DETECTION OF BONE METASTASIS IN BREAST-CANCER PATIENTS

AYDINER A., TOPUZ E., DISCI R., YASASEVER v., DINCER M., DINCOL K., et al.

ACTA ONCOLOGICA, vol.33, no.2, pp.181-186, 1994 (SCI-Expanded) Sustainable Development

NEOADJUVANT CHEMOTHERAPY AND RADIOTHERAPY IN LOCALLY ADVANCED UNDIFFERENTIATED NASOPHARYNGEAL CARCINOMA

Onat H., Altun M., Bılge N., Karadenız A. N., Erturk N., Aydıner A., et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, vol.11, pp.203-206, 1992 (SCI-Expanded)

Articles Published in Other Journals

Effect of Astragalus Membranaceus on Patients with Metastatic Non-Small Cell Lung Cancer: A Retrospective Cohort Study

Ak N., Ciftci R., Cabioglu N., Aydiner A.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY, vol.36, no.2, pp.215-221, 2021 (ESCI) Sustainable Development

Preliminary testing of a Turkish version of the Strategies Used by Patients to Promote Health (SUPPH) Scale in a sample of breast cancer patients

Akin S., CAN G., Durna Z., AYDINER A.

Journal of Nursing and Healthcare of Chronic Illness, vol.1, no.4, pp.303-310, 2009 (Peer-Reviewed Journal) Sustainable Development

Immune changes in patients with locally advenced breast cancer receiving neoadjuvant chemotherapy.

CABIOĞLU N., MÜSLÜMANOĞLU M. E., Tütüncü Y., ÇINAR S., Gürel N., Kıran B., et al.

Türk İmmünoloji Dergisi, vol.13, pp.15-20, 2008 (Peer-Reviewed Journal) Sustainable Development

Clinical usefulness of serum assays of carcinoembryonic antigen and beta 2-microglobulin in the diagnosis and discrimination of metastasis of lung cancer

Taş F., Aydıner A., Yasasever V., Dişçi R., Topuz E.

Turkish Journal of Cancer, vol.30, pp.148-154, 2000 (Scopus) Sustainable Development

Refereed Congress / Symposium Publications in Proceedings

The Contribution of 18 F-FES PET/CT in Therapy Management of Estrogen Receptor Positive Breast Cancer

Oflas M., Has Şimşek D., Işık E. G., Cabıoğlu N., İbiş K., Aydıner A., et al.

35'th Annual Congress of Nuclear Medicine, Barcelona, Spain, 15 - 19 October 2022

Outcomes and prognostic factors in patients with HER2-positive metastatic breast cancer with brain metastasis

Dogan I., Kızıldağ Yırgın İ., Özkurt S., İbiş K., Vatansever S., Saip P. M., et al.

2022 ASCO Annual Meeting , Illinois, United States Of America, 3 - 07 June 2022, pp.14002 Sustainable Development

The Contribution of 18F-FES PET/CT to Therapy Management in Estrogen Receptor Positive Breast Cancer

Oflas M., Has Şimşek D., Işık E. G., Cabıoğlu N., İbiş K., Aydıner A., et al.

34. Ulusal Nükleer Tıp Kongresi, Antalya, Turkey, 27 - 31 March 2022, pp.51

Timik Epitelyal Tümörlerde Ga-68 DOTATATE PET/BT Görüntüleme Caner

Civan C., Özkan Z. G., Özkan B., Işık E. G., Has Şimşek D., Aydıner A., et al.

34. ULUSAL NÜKLEER TIP KONGRESI , Antalya, Turkey, 27 March - 31 May 2022, pp.16

EGFR mutasyonlu Metastatik Küçük Hücreli Dışı Akciğer Kanserli Hastalarda Erlotinibin Etkinliğinin Değerlendirilmesi.

Doğan İ., Paksoy N., Kızıldağ Yırgın İ., Aydıner A.

Ulusal Akciğer Sağlığı Kongresi 2021, Antalya, Turkey, 7 - 10 October 2021, pp.187 Sustainable Development

Clinicopathologic features and prognostic factors in male breast cancer: A single centre experience

DOĞAN İ., AYDIN E. M., AK N., İBİŞ K., Sukruoglu Ö., Erciyas S., et al.

ESMO Asia Virtual Congress, ELECTR NETWORK, 20 - 22 November 2020, vol.31

Neoadjuvam kemoterapi öncesi biyopsi ile doğrulanmış aksiller metastazı olan hangi hasta grubunda tedavi sonrası aksiller diseksiyon göz ardı edilebilir?

Karanlık H., Özgür İ., Bademler S., Şen F., Eralp Y., Fayda M., et al.

20. Ulusal Cerrahi Kongresi, 2016, Antalya, Turkey, 13 - 17 April 2016, pp.1

İleri yaş erken evre meme kanserlerinde lokal anestezi altında meme cerrahisi.

Karanlık H., Özgür İ., Kılıç B., Bademler S., Şen F., Eralp Y., et al.

13. Ulusal Meme Hastalıkları Kongresi, 2015, Antalya, Turkey, 21 - 25 October 2015, pp.1 Sustainable Development

Clinical distuingishing characteristics and management of phyllodes tumors of the breast.

Tukenmez M., Kulle C. B., Velidedeoglu M., Agcaoglu O., Parlakgul G., Aydogan F., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33

Factors affecting progression free survival in non-HIV related classical Kaposi sarcoma.

Sen F., Tambas M., Ciftci R., Toz B., Kilic L., Bozbey H. U., et al.

Effect of renin-angiotensin system blockers on survival of metastatic non-small cell lung cancer patients receiving erlotinib.

Aydiner A., Ciftci R., Sen F.

Investigation of mir-15a/mir-16-1 expression levels in B-cell non-Hodgkin lymphomas.

Yazici H., kılıç S., avşar M., Sukruoglu O., AKDENIZ D., Ekenel M., et al.

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America, 30 May - 03 June 2014, vol.32

Clinical significance of serum epithelial cell adhesion molecule (EPCAM) cud vascular cell adhesion molecule-1 (VCAM-1) levels in lung cancer.

KARABULUT S., Tastekin D., CIFTCI R., Tambas M., DAGOGLU N., Guveil M. E., et al.

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America, 30 May - 03 June 2014, vol.32 Sustainable Development

Association of NBS1 expression with improved pathologic complete response rate in HER2-overexpressing breast cancer.

Sen F., Yavuz E., Yegen G., Karanlik H., Tuzlali S., Aydiner A.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31 Sustainable Development

Clinicopathological characteristics and survival rate in patients with BRCA1/2 linked ovarian cancer in Turkey

KESKİN S., EKENEL M., KILIC S., SUKRUOGLU O., AYDINER A., ERALP Y., et al.

2nd Mediterranean Multidisciplinaty Oncology Forum, İstanbul, Turkey, 17 - 19 November 2011 Sustainable Development

Kaposi Sarkomlu Hastalarda E-Cadherin Gen Mutasyonlarının Araştırılması

TUNÇER Ş. B., ŞEN F., kılıç s., KURUL S., AYDINER A., YAZICI H., et al.

19.Ulusal Kanser Kongresi, Antalya, Turkey, 21 - 24 April 2011, pp.502

HIV-Negatif Kaposi Sarkomlu Hastalarda Serum Human Herpes Virus 8 DNA Pozitiflik Oranı

ŞEN F., TUNÇER Ş. B., YAZICI H., KURUL S., KARANLIK H., AYDINER A.

19.Ulusal Kanser Kongresi, Antalya, Turkey, 21 - 24 April 2011, pp.311 Sustainable Development

HIV-Negatif Kaposi Sarkomunda Penis ve Skrotum Tutulumu

ŞEN F., Yıldız İ., KARANLIK H., TOZ B., TUNÇER Ş. B., Ünal E., et al.

19.Ulusal Kanser Kongresi, Antalya, Turkey, 21 - 24 April 2011, pp.618 Sustainable Development

Meme kanseri hastalarında yeniden evrelendirme amaçlı PET-BT'nin rolü

KUYUMCU S., KARAGÖZ F., ŞANLI Y., EKENEL M., YILDIZ İ., KARABULUT S., et al.

19. Ulusal Kanser Kongresi, Antalya, Turkey, 20 - 24 April 2011, pp.423 Sustainable Development

LOKAL İLERİ MEME KANSERİNDE NEOADJUVAN TEDAVİ AMAÇLI ANTRASİKLİN BAZLI KEMOTERAPİ REJİMİ İLE ANTRASİKLİNE EK OLARAK VERİLEN DOSETAKSELLİ TEDAVİ YÖNTEMLERİNİN KARŞILAŞTIRILMASI

Canbay E., Özçınar B., Özmen V., Müslümanoğlu M. E., Eralp Y., Aydıner A., et al.

İSTANBUL MEME KANSERİ KONFERANSI VE ULUSAL MEME KANSERİ KONSENSUS TOPLANTISI 2008, İstanbul, Turkey, 21 - 25 October 2008, pp.247 Sustainable Development

MEMENİN FİLLODES TÜMÖRLERİNDE TEDAVİ YAKLAŞIMLARI

Çelik T., Cabıoğlu N., Özmen V., İğci A., Müslümanoğlu M. E., Özçınar B., et al.

9. ULUSAL MEME HASTALIKLARI KONGRESİ, Ankara, Turkey, 5 - 09 September 2007, pp.47

NEOADJUVAN KEMOTERAPİ SONRASI MEME KORUYUCU CERRAHİDE LOKAL NÜKSÜ ETKİLEYEN FAKTÖRLER: UZUN DÖNEM SONUÇLARIMIZ

Cabıoğlu N., Özçınar B., Müslümanoğlu M. E., Özmen V., İğci A., Dağoğlu T., et al.

9. ULUSAL MEME HASTALIKLARI KONGRESİ, Ankara, Turkey, 5 - 09 September 2007, pp.40

Induction chemotherapy followed by chemoradiotherapy in patients with stage IIIA-B non-small cell lung cancer (NSCLC)

DAĞOĞLU SAKİN R. N., AYDINER A., Sakallioglu B., Ozturk B., Eralp Y., SAİP P. M., et al.

31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 29 September - 03 October 2006, vol.17, pp.229

The efficacy of tamoxifen in patients with advanced epithelial ovarian cancer

Karagol H., Saip P., Uygun K., Caloglu M., Eralp Y., Tas F., et al.

31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 29 September - 03 October 2006, vol.17, pp.174 Sustainable Development

Alteration in cellular immunity in patients with advanced breast cancer after neoadjuvant chemotherapy.

Müslümanoğlu M., Cabıoğlu N., Deniz G., Tütüncü Y., Çınar S., Polat N. S., et al.

American Society of Clinical Oncology 34th Annual Meeting , California, United States Of America, 16 - 19 May 1998, pp.618 Sustainable Development

Oral etoposide in patients with small cell lung cancer

TOPUZ E., TAŞ F., AYDINER A., DEMİR C., SAİP P. M., SALEPÇİ T., et al.

EUROPEAN JOURNAL OF CANCER, Oxford, United Kingdom, 01 September 1997, vol.33, no.8, pp.1072 Sustainable Development

Oral etoposide in patients (pts) with Kaposi's sarcoma (KS)

AYDINER A., TAS F., SAİP P. M., KARADENİZ A. N., DEMİR C., SALEPÇİ T., et al.

EUROPEAN JOURNAL OF CANCER, Oxford, United Kingdom, 01 September 1997, vol.33, no.8, pp.1178

Dimetil sülfoksit ve antineoplastik kombinasyonların FMA3 hücre kültürlerinde koloni oluşumu üzerine etkileri

BİLİR A., Özmen V., Müslümanoğlu M., İĞCİ A., bozfakioğlu Y., ASLAY I., et al.

IV. Ulusal Meme Hastalıkları Kongresi, İzmir, Turkey, 1 - 04 March 1997, pp.95

Adenokistik karsinomda sisplatin, epirubisin, fluorourasil (PEF) kombinasyon kemoterapinin etkinliği

İNANÇ S., ONAT H., ALTUN M., AYDINER A., TOPUZ E.

XI. Ulusal Kanser Kongresi, Antalya, Turkey, 28 May - 02 June 1995, pp.43

Lokal tedavi sonrası rezidiv, lokal nüks ve uzak metastazı olan baş-boyun kanserli hastalarda tek ajanlı kemoterapi sonuçları

İNANÇ S., ONAT H., AYDINER A., ÖZTÜRK N., AYKAN F., ALTUN M., et al.

IV. Kemoterapi Kongresi, Bursa, Turkey, 29 - 31 October 1992, pp.31 Sustainable Development

Books & Book Chapters

Jinekolojik Tümörler. Tanı-Tedavi-Takip

Engin G., Aydıner A. (Editor)

Nobel Tıp Kitapevi, İstanbul, 2017

Publications & Works

Published journal articles indexed by SCI, SSCI, and AHCI

Articles Published in Other Journals

Refereed Congress / Symposium Publications in Proceedings

Books & Book Chapters